RESUMEN
Brown adipose tissue (BAT) plays an important role in lipid and glucose metabolism in rodents and possibly also in humans. Identification of genes responsible for BAT function would shed light on underlying pathophysiological mechanisms of metabolic disturbances. Recent linkage analysis in the BXH/HXB recombinant inbred (RI) strains, derived from Brown Norway (BN) and spontaneously hypertensive rats (SHR), identified two closely linked quantitative trait loci (QTL) associated with glucose oxidation and glucose incorporation into BAT lipids in the vicinity of Wars2 (tryptophanyl tRNA synthetase 2 (mitochondrial)) gene on chromosome 2. The SHR harbors L53F WARS2 protein variant that was associated with reduced angiogenesis and Wars2 thus represents a prominent positional candidate gene. In the current study, we validated this candidate as a quantitative trait gene (QTG) using transgenic rescue experiment. SHR-Wars2 transgenic rats with wild type Wars2 gene when compared to SHR, showed more efficient mitochondrial proteosynthesis and increased mitochondrial respiration, which was associated with increased glucose oxidation and incorporation into BAT lipids, and with reduced weight of visceral fat. Correlation analyses in RI strains showed that increased activity of BAT was associated with amelioration of insulin resistance in muscle and white adipose tissue. In summary, these results demonstrate important role of Wars2 gene in regulating BAT function and consequently lipid and glucose metabolism.
Asunto(s)
Tejido Adiposo Pardo/metabolismo , Metabolismo Energético , Grasa Intraabdominal/metabolismo , Mutación , Obesidad/genética , Triptófano-ARNt Ligasa/genética , Tejido Adiposo Pardo/patología , Animales , Células Cultivadas , Metabolismo Energético/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Glucosa/metabolismo , Grasa Intraabdominal/fisiopatología , Metabolismo de los Lípidos , Masculino , Mitocondrias/metabolismo , Obesidad/metabolismo , Obesidad/fisiopatología , Fenotipo , Sitios de Carácter Cuantitativo , Ratas Endogámicas SHRRESUMEN
In contrast to the well-established anti-apoptotic effect of Bcl-2 protein, we have recently demonstrated that Bcl-2 overexpression by vaccinia virus causes apoptosis in BSC-40 cells, while it prevents apoptosis in HeLa G cells. Given the key role of mitochondria in the process of apoptosis, we focused on effects of Bcl-2 expression on mitochondrial energetics of these two cell lines. In this study we present data indicating that BSC-40 cells derive their ATP mainly from oxidative phosphorylation whereas HeLa G cells from glycolysis. More importantly, we show that in both cell lines, Bcl-2 inhibits mitochondrial respiration and causes a decrease of the ATP/ADP ratio. However, it appears that BSC-40 cells cannot sustain this decrease and die, while HeLa G cells survive, being adapted to the low ratio of ATP/ADP maintained by glycolysis. Based on this observation, we propose that the outcome of Bcl-2 expression is determined by the type of cellular ATP synthesis, namely that Bcl-2 causes apoptosis in cells relying on oxidative phosphorylation.
Asunto(s)
Respiración de la Célula/fisiología , Mitocondrias/fisiología , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Carbonil Cianuro p-Trifluorometoxifenil Hidrazona/farmacología , Línea Celular Transformada , Respiración de la Célula/efectos de los fármacos , Digitonina/farmacología , Expresión Génica , Células HeLa , Humanos , Mitocondrias/efectos de los fármacos , Oligomicinas/farmacología , Consumo de Oxígeno/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/genética , Rotenona/farmacología , Ácido Succínico/farmacología , TransfecciónRESUMEN
Using a recombinant vaccinia virus expressing protooncogene Bcl-2, we demonstrate opposite effects of the expressed Bcl-2 in two cell lines: apoptosis induction in BSC-40 cells and apoptosis prevention in HeLa G cells. The apparent molecular weight of the expressed Bcl-2, its amounts and its effects on the mitochondrial membrane potential are comparable in both cell lines, suggesting that the consequences of Bcl-2 expression depend on the cellular environment. To further support these findings we demonstrate the pro-apoptotic effect of the expressed Bcl-2 in several other cell lines.
Asunto(s)
Apoptosis/genética , Genes bcl-2 , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Animales , Caspasas/metabolismo , Línea Celular/citología , Cloranfenicol O-Acetiltransferasa/genética , Chlorocebus aethiops , Células Epiteliales/citología , Genes Reporteros , Vectores Genéticos/genética , Células HeLa/citología , Humanos , Membranas Intracelulares/fisiología , Células Jurkat/citología , Potenciales de la Membrana , Mitocondrias/fisiología , Proteínas Recombinantes de Fusión/fisiología , Especificidad de la Especie , TransfecciónRESUMEN
Disorders of ATP synthase, the key enzyme of mitochondrial energy provision belong to the most severe metabolic diseases presenting as early-onset mitochondrial encephalo-cardiomyopathies. Up to now, mutations in four nuclear genes were associated with isolated deficiency of ATP synthase. Two of them, ATP5A1 and ATP5E encode enzyme's structural subunits alpha and epsilon, respectively, while the other two ATPAF2 and TMEM70 encode specific ancillary factors that facilitate the biogenesis of ATP synthase. All these defects share a similar biochemical phenotype with pronounced decrease in the content of fully assembled and functional ATP synthase complex. However, substantial differences can be found in their frequency, molecular mechanism of pathogenesis, clinical manifestation as well as the course of the disease progression. While for TMEM70 the number of reported patients as well as spectrum of the mutations is steadily increasing, mutations in ATP5A1, ATP5E and ATPAF2 genes are very rare. Apparently, TMEM70 gene is highly prone to mutagenesis and this type of a rare mitochondrial disease has a rather frequent incidence. Here we present overview of individual reported cases of nuclear mutations in ATP synthase and discuss, how their analysis can improve our understanding of the enzyme biogenesis.
Asunto(s)
Predisposición Genética a la Enfermedad/genética , Mitocondrias/enzimología , Mitocondrias/genética , Enfermedades Mitocondriales/enzimología , Enfermedades Mitocondriales/genética , ATPasas de Translocación de Protón Mitocondriales/genética , Mutación/genética , Animales , Humanos , Mitocondrias/patología , Modelos Genéticos , Polimorfismo de Nucleótido Simple/genéticaRESUMEN
Dicarbanonaborates inhibit the mitochondrial cytochrome c oxidase activity. In contrast to mitochondrial ATPase or glycerol phosphate dehydrogenase, inhibition of cytochrome c oxidase was not competitive and the residual, drug-insensitive activity was higher. These results indicate that dicarbanonaborates inhibit various mitochondrial membrane-bound enzymes through different mechanisms.